Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012

Scott Epperson1, Michael Jhung, Shawn Richards

  • 1Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Atlanta, GA 30333, USA. sepperson@cdc.gov

Insights

Human infections with a novel influenza A(H3N2) variant (H3N2v) virus, containing a gene from the 2009 pandemic strain, were identified in children. Limited person-to-person transmission occurred, raising concerns about its potential for efficient spread.

Area of Science:

  • Virology
  • Epidemiology

Background:

  • Influenza A(H3N2) variant (H3N2v) virus infections in humans are rare.
  • This H3N2v strain contains the matrix (M) gene from the Influenza A(H1N1)pdm09 pandemic virus, differentiating it from previous variant strains.

Observation:

  • Between August 2011 and April 2012, 13 human H3N2v infections were identified in the US, with a median age of 4 years.
  • Fifty-four percent of cases reported exposure to swine, with most involving direct contact.
  • Two clusters of suspected person-to-person transmission were identified, even in cases without swine exposure.

Findings:

  • All 13 cases experienced fever and respiratory symptoms; 23% were hospitalized.
  • The H3N2v virus demonstrated limited person-to-person transmission during influenza-like illness outbreaks.
  • Children represent a highly susceptible population due to minimal pre-existing immunity and limited cross-protection from seasonal vaccines.

Implications:

  • The H3N2v virus's potential for efficient person-to-person transmission is a significant public health concern.
  • The lack of pre-existing immunity in children necessitates careful monitoring and potential intervention strategies.
  • Understanding the transmission dynamics of variant influenza viruses is crucial for pandemic preparedness.

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Vaccinations01:51

Vaccinations

Overview